CD Bioparticles Launches Custom Latex Immunoturbidimetric Assay (LIA) Development Services to Accelerate IVD Innovation
Sep 22, 2026
CD Bioparticles launches end-to-end Custom Latex Immunoturbidimetric Assay development services for research applications.
New York, NY, United States, September 22, 2026 /MarketersMEDIA/ -- With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its diagnostic capabilities with the launch of its end-to-end Custom Latex Immunoturbidimetric Assay development services. These services offer full-spectrum assay customization ranging from particle conjugation to fully optimized kit assembly, and can help researchers and diagnostic developers to streamline IVD reagent manufacturing and clinical biomarker quantification.
The immunoturbidimetry method is an analytical technique combining liquid-phase precipitation reactions with optical instruments and automated analysis. However, due to issues relating to the size and quantity of antigen-antibody complexes, the immunoturbidimetry has low sensitivity and a narrow detection range. This has led to the development of the latex immunoturbidimetric assay (LIA). This technique uses latex microparticles that are coated with specific antibodies or antigens.
When these particles encounter the target analyte in a sample, they form specific aggregates through antigen-antibody interactions. The aggregation of these particles increases the scattering intensity or absorbance of the latex suspension. This increase is quantitatively correlated with the concentration of the target analyte in the sample. Turbidity measurements are performed using a biochemical analyser, and the entire analytical process takes only a few minutes. Compared to traditional immunoturbidimetric methods, this method offers significantly higher sensitivity, with detection limits as low as ng/mL or pg/mL.
CD Bioparticles has extensive experience in assay solutions and now offers custom services to help researchers and diagnostic product developers develop latex immunoturbidimetric assays. The company's service portfolio ranges from custom conjugation to the optimization of complete immunoturbidimetric assays. The company provides custom-made, carboxyl-functionalized polystyrene microspheres that are conjugated with antigens or antibodies and come in various sizes. CD Bioparticles also offers complete kits for the quantitative detection of a wide range of biomarkers. These products feature high sensitivity, short assay times and compatibility with automated biochemical analyzers.
CD Bioparticles offers customers carboxyl-modified polystyrene microparticles in a range of sizes (from 0.07 to 0.4 μm) that are suitable for developing latex immunoturbidimetric assay reagents. CD Bioparticles' standard products feature a moderate surface carboxyl density; products with higher or lower densities are also available upon request. Additionally, CD Bioparticles can customize the conjugation of antibodies and antigens to meet specific application requirements. Through optimization, the team can ensure high conjugation efficiency while maintaining the activity of both antibodies and antigens.
CD Bioparticles also offers reagent formulation development and optimization services to help customers improve reagent stability, optimize reaction conditions and enhance detection sensitivity. The company offers performance validation services to verify key performance indicators, including linearity, sensitivity, specificity and precision, ensuring stability across different batches and under various operating conditions.
For more information about CD Bioparticles' Custom Latex Immunoturbidimetric Assay development services or to submit a project inquiry, please visit https://www.cd-bioparticles.com/services/latex-immunoturbidimetric-assay-development.html.
About CD Bioparticles
CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.
Contact Info:
Name: Richard J. Gray
Email: Send Email
Organization: CD Bioparticles
Website: https://www.cd-bioparticles.com/
Release ID: 89204007
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.
More News
European pharma chiefs warn region risks losing ground to America, China
Drugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a disparity in access with the US, unless the region's healthcare systems agree to boost spending.
Afghan cyclist Fariba Hashimi who disguised herself as man wins Asian Games silver
Afghan cyclist Fariba Hashimi won a silver medal in the women's road race at the Asian Games near Nagoya, Japan, after overcoming restrictions on women in Afghanistan and leaving the country following the Taliban's return to power in 2021. Hashimi, who once trained disguised as a man, said she hoped her medal would inspire Afghan women and future generations to pursue their dreams without fear.
Iran is waiting to see how I do in mid-term election: Trump
Trump called for the complete economic isolation of Iran in his UN speech, while saying he expected a deal with Tehran after the November midterm elections. Iran said it could reopen the Strait of Hormuz within seven days if US military pressure and the blockade on Iranian ports were eased. Trump also described Cuba as a failed state.
UK to provide Saudi Arabia defensive air-refuelling support against Houthis
The UK has decided to assist Saudi Arabia's military by providing defensive air-to-air refueling support. This agreement follows a request made by Saudi Arabia to enhance their operational capabilities against the Houthi militants. Prime Minister Andy Burnham confirmed that this military help would be the first of its kind from a foreign country. Saudi Arabia has also sought similar support from the Americans to bolster their defenses.
US midterm elections 2026: A new Congress could change Trump's legislative agenda; what house control means for Washington
US midterm elections 2026: Forecasts suggest that Democrats could clinch around 226 seats in the House during the 2026 midterm elections, while the Senate election is shaping up to be a tightly contested affair. This period will be pivotal for Congress as it navigates funding the government and raising the debt ceiling for President Trump.
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gap
Supreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a serious issue for patients and taxpayers. The bench said such disparities could lead to excessive costs under government health schemes and sought greater scrutiny of medicine pricing. The court was hearing a petition on generic prescriptions and price controls.
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gap
Supreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a serious issue for patients and taxpayers. The bench said such disparities could lead to excessive costs under government health schemes and sought greater scrutiny of medicine pricing. The court was hearing a petition on generic prescriptions and price controls.
Maharashtra drought deepens, crop output crisis mounts
State agriculture minister Dattatray Bharane has confirmed a large contraction in the production of cotton and soybean, while the agriculture department has initiated an early crop assessment to calculate compensation as farmers are removing wilted crops from fields.
DNA reveals four gentoo penguin species instead of one after more than 100 years. Scientists now fear some island populations could lose their homes to global warming
New genomic research has resolved a century-old debate over gentoo penguins, revealing four distinct species rather than one with several subspecies. The newly recognised Kerguelen gentoo lives on remote islands in the Southern Indian Ocean. Scientists warn that warming temperatures could shrink habitats for several island populations, making conservation increasingly important.
Look beyond premiumisation: FM Nirmala Sitharaman to India Inc
Sitharaman made a strong pitch for better-governed family businesses and greater corporate spending on research and development. She said the next 20 years would require Indian businesses to move beyond the creation of startups towards building enterprises that could scale, professionalise and endure.
Man tries to commit insurance fraud by setting car ablaze, blames fire on accident; arrested
Gondal Taluka police in Rajkot district have initiated proceedings against 26-year-old Deep Virdiya, who allegedly set his overturned car on fire to create the appearance of accidental damage and claim insurance money. Police said petrol was poured over the vehicle before it was ignited, while Virdiya allegedly told investigators the fire was caused by a short circuit.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.